Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis

小核仁 RNA 加剧动脉粥样硬化的机制

基本信息

  • 批准号:
    10670399
  • 负责人:
  • 金额:
    $ 58.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-01 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Superoxide and other derivative reactive oxygen species (ROS) promote atherosclerosis (athero) as well as vascular smooth muscle cell (SMC) and macrophage inflammatory signaling. Anti-atherogenic strategies targeting O2--producing NADPH oxidases, however, increase susceptibility to infection. This project’s goal is to discern novel mechanisms for constraining ROS-promoted atherogenesis while minimizing adverse effects on immunity. One such mechanism may involve the ubiquitously expressed noncoding small nucleolar (sno) RNAs from the ribosomal protein L13a (Rpl13a) locus: SNORD32A, SNORD33, SNORD34, and SNORD35A. We found that these snoRNAs augment ROS levels and oxidative stress in vitro and in vivo. Our Preliminary Studies with Rpl13a-snoRNA-/- (snoKO) mice and SMCs derived from them show: (1) snoKO SMCs have lower levels of ROS, cell proliferation and migration than congenic WT SMCs. (2) Compared with WT SMCs, snoKO SMCs express 5.7-fold more cytochrome C oxidase subunit 4 isoform 2 (COX4I2), which reduces mitochondrial O2- production. (3) SnoKO carotid arteries develop less athero than WT carotids when transplanted orthotopically into Apoe-/- mice. (4) Compared with Apoe-/- mice, snoKO/Apoe-/- mice develop 40% less brachiocephalic athero. (5) Compared with snoRNA+/+ brachiocephalic arteries or carotid grafts, snoKO arteries demonstrate less SMC-to-foam-cell transdifferentiation, a process potentiated by ROS. SnoRNAs bind to their target RNAs via an antisense domain, then recruit the enzyme fibrillarin, which effects RNA 2’-O-methylation. SnoRNAs canonically modify ribosomal RNA; however, we discovered that at least one of the Rpl13a snoRNAs can target mRNA for 2’-O-methylation—a process that alters mRNA abundance and translation. Nonetheless, specific mRNAs that constitute targets for pro-oxidant effects of Rpl13a-snoRNAs remain obscure. This project will therefore test the hypotheses that Rpl13a snoRNAs promote athero, particularly by potentiating SMC-to-foam cell transdifferentiation, and that that Rpl13a-snoRNA-guided mRNA 2’-O-methylation affects protein expression of key ROS-regulating enzyme(s) in SMCs and Mφs, including COX4I2. To do so, this project will compare athero in Rpl13a-snoRNA-/-/Apoe-/- versus Apoe-/- mice, and use bone marrow transplantation to discern the roles of Rpl13a-snoRNAs in bone marrow-derived cells versus arterial wall-derived cells. We will investigate how Rpl13a-snoRNAs affect foam cell formation in macrophages and SMCs, and determine whether COX4I2 engenders lower ROS levels and inflammation in snoKO SMCs. Finally, we will identify mRNA targets of Rpl13a-snoRNAs in SMCs and macrophages, by performing transcriptome-wide mapping of 2’-O-methylation sites on mRNA from WT and Rpl13a-snoRNA-/- SMCs and macrophages, by using the RibOxi-seq and crosslinking, ligation, and sequencing of hybrids (CLASH) approach. By elucidating mechanisms by which snoRNAs regulate ROS in SMCs and macrophages, this project should identify new therapeutic targets for athero.
超氧化物和其他衍生的活性氧物质(ROS)促进动脉粥样硬化(athero), 血管平滑肌细胞(SMC)和巨噬细胞炎症信号。抗动脉粥样硬化策略 然而,靶向产生O2的NADPH氧化酶增加了对感染的易感性。该项目的目标是 识别抑制ROS促进的动脉粥样硬化形成的新机制,同时最大限度地减少对 免疫力其中一个机制可能涉及广泛表达的非编码小核仁(sno) 来自核糖体蛋白L13 a(Rpl 13 a)基因座的RNA:SNORD 32A、SNORD 33、SNORD 34和SNORD 35 A。 我们发现这些snoRNA在体外和体内增加ROS水平和氧化应激。我们的初步 用Rpl 13 a-snoRNA-/-(snoKO)小鼠和源自它们的SMC的研究显示:(1)snoKO SMC具有以下特性: 较低水平的ROS、细胞增殖和迁移。(2)与WT SMC相比, snoKO SMC表达的细胞色素C氧化酶亚基4同种型2(COX 4 I2)是对照组的5.7倍, 线粒体O2生成。(3)SnoKO颈动脉比WT颈动脉发生更少的动脉粥样硬化, 原位移植到Apoe-/-小鼠中。(4)与Apoe-/-小鼠相比,snoKO/Apoe-/-小鼠发育 头臂动脉粥样硬化减少40%。(5)与snoRNA+/+头臂动脉或颈动脉移植物相比, snoKO动脉表现出较少的SMC到泡沫细胞的转分化,这是一个由ROS增强的过程。 SnoRNA通过反义结构域与它们的靶RNA结合,然后募集纤维素酶, RNA 2 '-O-甲基化。SnoRNA通常修饰核糖体RNA;然而,我们发现,至少有一个 的Rpl 13 a snoRNA可以靶向mRNA进行2 '-O-甲基化-这一过程改变mRNA丰度, 翻译.尽管如此,构成Rpl 13 a-snoRNA的促氧化作用的靶标的特异性mRNA 保持模糊。因此,该项目将测试Rpl 13 a snoRNA促进动脉粥样硬化的假设, 特别是通过增强SMC向泡沫细胞的转分化,并且Rpl 13 a-snoRNA引导的mRNA 2 '-O-甲基化影响SMC和Mφ中关键ROS调节酶的蛋白表达,包括 COX4I2。为此,该项目将比较Rpl 13 a-snoRNA-/-/Apoe-/-与Apoe-/-小鼠中的动脉粥样硬化,并使用 骨髓移植以辨别Rpl 13 a-snoRNA在骨髓来源的细胞中的作用, 动脉壁来源的细胞。我们将研究Rpl 13 a-snoRNA如何影响巨噬细胞中泡沫细胞的形成 和SMC,并确定COX 4 I2是否在snoKO SMC中产生较低的ROS水平和炎症。 最后,我们将通过执行以下操作来识别SMC和巨噬细胞中Rpl 13 a-snoRNA的mRNA靶点: 来自WT和Rpl 13 a-snoRNA-/-SMC的mRNA上的2 '-O-甲基化位点的全转录组作图,以及 巨噬细胞,通过使用RibOxi-seq和杂交体的交联、连接和测序(CLASH) approach.通过阐明snoRNA调节SMC和巨噬细胞中ROS的机制, 该项目应确定动脉粥样硬化的新治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NEIL J. FREEDMAN其他文献

NEIL J. FREEDMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NEIL J. FREEDMAN', 18)}}的其他基金

Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
小核仁 RNA 加剧动脉粥样硬化的机制
  • 批准号:
    10502380
  • 财政年份:
    2022
  • 资助金额:
    $ 58.7万
  • 项目类别:
Anti-Atherogenic Mechanisms of Drebrin
Drebrin 的抗动脉粥样硬化机制
  • 批准号:
    10318175
  • 财政年份:
    2019
  • 资助金额:
    $ 58.7万
  • 项目类别:
Anti-Atherogenic Mechanisms of Drebrin
Drebrin 的抗动脉粥样硬化机制
  • 批准号:
    10532356
  • 财政年份:
    2019
  • 资助金额:
    $ 58.7万
  • 项目类别:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
去泛素酶 USP20 对血管炎症信号的调节
  • 批准号:
    9765984
  • 财政年份:
    2019
  • 资助金额:
    $ 58.7万
  • 项目类别:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
去泛素酶 USP20 对血管炎症信号的调节
  • 批准号:
    9893026
  • 财政年份:
    2019
  • 资助金额:
    $ 58.7万
  • 项目类别:
Anti-Atherogenic Mechanisms of Drebrin
Drebrin 的抗动脉粥样硬化机制
  • 批准号:
    9887940
  • 财政年份:
    2019
  • 资助金额:
    $ 58.7万
  • 项目类别:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
去泛素酶 USP20 对血管炎症信号的调节
  • 批准号:
    10349573
  • 财政年份:
    2019
  • 资助金额:
    $ 58.7万
  • 项目类别:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
去泛素酶 USP20 对血管炎症信号的调节
  • 批准号:
    10112295
  • 财政年份:
    2019
  • 资助金额:
    $ 58.7万
  • 项目类别:
Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20
去泛素酶 USP20 对 B-arrestin2 促动脉粥样硬化活性的调节
  • 批准号:
    8797106
  • 财政年份:
    2014
  • 资助金额:
    $ 58.7万
  • 项目类别:
Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20
去泛素酶 USP20 对 B-arrestin2 促动脉粥样硬化活性的调节
  • 批准号:
    8639259
  • 财政年份:
    2014
  • 资助金额:
    $ 58.7万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 58.7万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 58.7万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 58.7万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 58.7万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 58.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 58.7万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 58.7万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 58.7万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 58.7万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 58.7万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了